Publications by authors named "Sara M Balch"

Claim this Profile
A
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.
Sara M Balch, Ines Vaz-Luis, Tianyu Li, Nabihah Tayob, Esha Jain

Breast Cancer Res Treatยท September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis